Published in Ann N Y Acad Sci on January 12, 2012
Coinfection. Virus-helminth coinfection reveals a microbiota-independent mechanism of immunomodulation. Science (2014) 2.19
Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths. Nat Rev Immunol (2013) 1.96
Effect of helminth-induced immunity on infections with microbial pathogens. Nat Immunol (2013) 1.55
Cytokine, antibody and proliferative cellular responses elicited by Taenia solium calreticulin upon experimental infection in hamsters. PLoS One (2015) 1.39
Genome of the human hookworm Necator americanus. Nat Genet (2014) 1.18
Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology (2014) 1.16
Helminthic therapy: improving mucosal barrier function. Trends Parasitol (2012) 1.06
Human helminth therapy to treat inflammatory disorders - where do we stand? BMC Immunol (2015) 0.99
Hookworm excretory/secretory products induce interleukin-4 (IL-4)+ IL-10+ CD4+ T cell responses and suppress pathology in a mouse model of colitis. Infect Immun (2013) 0.98
Epigenetics and the developmental origins of inflammatory bowel diseases. Can J Gastroenterol (2012) 0.97
Differences of larval development and pathological changes in permissive and nonpermissive rodent hosts for Angiostrongylus cantonensis infection. Parasitol Res (2012) 0.97
Where are we on worms? Curr Opin Gastroenterol (2012) 0.96
Immune regulation during helminth infections. PLoS Pathog (2013) 0.95
A role for IL-22 in the relationship between intestinal helminths, gut microbiota and mucosal immunity. Int J Parasitol (2012) 0.94
Unraveling the Hygiene Hypothesis of helminthes and autoimmunity: origins, pathophysiology, and clinical applications. BMC Med (2015) 0.93
Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression. Front Immunol (2013) 0.91
Accounting for reciprocal host-microbiome interactions in experimental science. Nature (2016) 0.90
Approaches to studying and manipulating the enteric microbiome to improve autism symptoms. Microb Ecol Health Dis (2015) 0.89
Excretory/secretory products from Trichinella spiralis adult worms ameliorate DSS-induced colitis in mice. PLoS One (2014) 0.89
The genomic landscape of human immune-mediated diseases. J Hum Genet (2015) 0.85
Toxoplasmosis and Polygenic Disease Susceptibility Genes: Extensive Toxoplasma gondii Host/Pathogen Interactome Enrichment in Nine Psychiatric or Neurological Disorders. J Pathog (2013) 0.85
Nematode asparaginyl-tRNA synthetase resolves intestinal inflammation in mice with T-cell transfer colitis. Clin Vaccine Immunol (2012) 0.84
Parasitic nematode-induced CD4+Foxp3+T cells can ameliorate allergic airway inflammation. PLoS Negl Trop Dis (2014) 0.83
Helminths and their implication in sepsis - a new branch of their immunomodulatory behaviour? Pathog Dis (2013) 0.81
Helminths and the microbiota: parts of the hygiene hypothesis. Parasite Immunol (2015) 0.81
The helminth Trichuris suis suppresses TLR4-induced inflammatory responses in human macrophages. Genes Immun (2014) 0.81
Clonorchis sinensis lysophospholipase inhibits TGF-β1-induced expression of pro-fibrogenic genes through attenuating the activations of Smad3, JNK2, and ERK1/2 in hepatic stellate cell line LX-2. Parasitol Res (2016) 0.81
State of the art of Taenia solium as compared to Taenia asiatica. Korean J Parasitol (2013) 0.80
Monotonous diets protect against acute colitis in mice: epidemiologic and therapeutic implications. J Pediatr Gastroenterol Nutr (2013) 0.80
Suppression of inflammation by helminths: a role for the gut microbiota? Philos Trans R Soc Lond B Biol Sci (2015) 0.80
The relationship between intestinal parasites and some immune-mediated intestinal conditions. Gastroenterol Hepatol Bed Bench (2015) 0.79
Diplomatic Assistance: Can Helminth-Modulated Macrophages Act as Treatment for Inflammatory Disease? PLoS Pathog (2016) 0.79
Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. J Immunol (2014) 0.79
Potential treatment of inflammatory bowel disease: a review of helminths therapy. Gastroenterol Hepatol Bed Bench (2014) 0.79
Innate immunity in disease. Clin Gastroenterol Hepatol (2014) 0.79
An experimental model of colitis induced by dextran sulfate sodium from acute progresses to chronicity in C57BL/6: correlation between conditions of mice and the environment. Gastroenterol Hepatol Bed Bench (2016) 0.79
The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Semin Immunopathol (2012) 0.78
Extraintestinal Helminth Infection Limits Pathology and Proinflammatory Cytokine Expression during DSS-Induced Ulcerative Colitis: A Role for Alternatively Activated Macrophages and Prostaglandins. Biomed Res Int (2015) 0.78
Nematode-derived proteins suppress proliferation and cytokine production of antigen-specific T cells via induction of cell death. PLoS One (2013) 0.78
TGF-β in tolerance, development and regulation of immunity. Cell Immunol (2015) 0.78
The common mouse protozoa Tritrichomonas muris alters mucosal T cell homeostasis and colitis susceptibility. J Exp Med (2016) 0.77
A prospective view of animal and human Fasciolosis. Parasite Immunol (2016) 0.77
Microbiome and mental health in the modern environment. J Physiol Anthropol (2016) 0.75
Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases. PLoS Genet (2015) 0.75
Have worms lost their luster? Inflamm Bowel Dis (2013) 0.75
Community deworming alleviates geohelminth-induced immune hyporesponsiveness. Proc Natl Acad Sci U S A (2016) 0.75
Changes in protein expression after treatment with Ancylostoma caninum excretory/secretory products in a mouse model of colitis. Sci Rep (2017) 0.75
Environmental influences on the onset and clinical course of Crohn's disease-part 2: infections and medication use. Gastroenterol Hepatol (N Y) (2013) 0.75
Influence of environmental factors on the onset and course of inflammatory bowel disease. World J Gastroenterol (2016) 0.75
A parasite-derived 68-mer peptide ameliorates autoimmune disease in murine models of Type 1 diabetes and multiple sclerosis. Sci Rep (2016) 0.75
Opposing macrophage polarization programs show extensive epigenomic and transcriptional cross-talk. Nat Immunol (2017) 0.75
Zoonotic Epidemic of Sporotrichosis: Cat to Human Transmission. PLoS Pathog (2017) 0.75
Trichinella spiralis infection changes immune response in mice performed abdominal heterotopic cardiac transplantation and prolongs cardiac allograft survival time. Parasitol Res (2015) 0.75
Exosomes Derived from Dendritic Cells Treated with Schistosoma japonicum Soluble Egg Antigen Attenuate DSS-Induced Colitis. Front Pharmacol (2017) 0.75
Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences. Gastroenterology (2004) 14.78
Experimental models of inflammatory bowel disease. Gastroenterology (1995) 6.28
The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol (2007) 6.19
Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26
Decreased atopy in children infected with Schistosoma haematobium: a role for parasite-induced interleukin-10. Lancet (2000) 4.32
Trichuris suis therapy in Crohn's disease. Gut (2005) 4.05
Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med (2005) 3.63
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40
Helminth immunoregulation: the role of parasite secreted proteins in modulating host immunity. Mol Biochem Parasitol (2009) 2.95
Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol (2007) 2.91
Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol (2009) 2.74
Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med (2010) 2.54
Alternatively activated macrophages in helminth infections. Curr Opin Immunol (2007) 2.41
Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28
A successful experience of soil-transmitted helminth control in the Republic of Korea. Korean J Parasitol (2006) 2.27
Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet (2001) 2.22
Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol (2010) 2.15
Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol (2007) 2.09
The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol (2011) 2.03
Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med (2009) 2.00
Does the failure to acquire helminthic parasites predispose to Crohn's disease? FASEB J (2000) 1.96
Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol (2004) 1.92
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis (2004) 1.85
Human intestinal parasites in the past: new findings and a review. Mem Inst Oswaldo Cruz (2003) 1.83
Helminths and the IBD hygiene hypothesis. Inflamm Bowel Dis (2009) 1.77
Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity. Clin Exp Allergy (2010) 1.73
Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice. Parasite Immunol (1999) 1.71
The multifaceted influence of the mucosal microflora on mucosal dendritic cell responses. Immunity (2009) 1.68
Intestinal helminths protect in a murine model of asthma. J Immunol (2006) 1.64
Revival of CD8+ Treg-mediated suppression. Trends Immunol (2008) 1.63
A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol (2003) 1.62
Impairment of dendritic cell function by excretory-secretory products: a potential mechanism for nematode-induced immunosuppression. Eur J Immunol (2007) 1.62
In vitro-derived alternatively activated macrophages reduce colonic inflammation in mice. Gastroenterology (2010) 1.61
Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes. Eur J Immunol (2003) 1.60
Helminth-induced CD19+CD23hi B cells modulate experimental allergic and autoimmune inflammation. Eur J Immunol (2010) 1.58
Review series on helminths, immune modulation and the hygiene hypothesis: mechanisms underlying helminth modulation of dendritic cell function. Immunology (2009) 1.48
Tolerogenic plasmacytoid DC. Eur J Immunol (2010) 1.48
A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut (2006) 1.48
Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun (2003) 1.45
Regulatory T cells in inflammatory bowel disease. Curr Opin Gastroenterol (2008) 1.44
A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol (2008) 1.43
Incidence and prevalence of ulcerative colitis in the Songpa-Kangdong District, Seoul, Korea, 1986-1997. J Gastroenterol Hepatol (2000) 1.43
IL-22+ CD4+ T cells are associated with therapeutic trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med (2010) 1.42
Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol (2009) 1.39
Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection. Infect Immun (2006) 1.38
Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35
Ascaris lumbricoides infection is associated with increased risk of childhood asthma and atopy in rural China. Am J Respir Crit Care Med (2002) 1.35
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect Immun (2007) 1.35
Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler (2011) 1.34
Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol (2003) 1.34
Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam. Clin Exp Allergy (2009) 1.33
Intestinal parasitism in the United States: update on a continuing problem. Am J Trop Med Hyg (1994) 1.32
Neutralizing anti-IL-10 antibody blocks the protective effect of tapeworm infection in a murine model of chemically induced colitis. J Immunol (2005) 1.32
The divergent roles of alternatively activated macrophages in helminthic infections. Parasite Immunol (2007) 1.31
Gene-environment interactions in chronic inflammatory disease. Nat Immunol (2011) 1.30
Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice. Eur J Immunol (2009) 1.29
Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am J Physiol Gastrointest Liver Physiol (2006) 1.28
Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001. World J Gastroenterol (2004) 1.25
Schistosoma mansoni infection reduces severity of collagen-induced arthritis via down-regulation of pro-inflammatory mediators. Int J Parasitol (2008) 1.21
Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness. J Immunol (2006) 1.21
Towards a molecular risk map--recent advances on the etiology of inflammatory bowel disease. Semin Immunol (2009) 1.18
Multiple sclerosis and regulatory T cells. J Clin Immunol (2008) 1.17
Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr Allergy Asthma Rep (2010) 1.15
Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. J Immunol (2006) 1.15
Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol (2009) 1.12
A helminth immunomodulator exploits host signaling events to regulate cytokine production in macrophages. PLoS Pathog (2011) 1.10
Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol (2010) 1.09
Helminth infection can reduce insulitis and type 1 diabetes through CD25- and IL-10-independent mechanisms. Infect Immun (2009) 1.07
Extracts of the rat tapeworm, Hymenolepis diminuta, suppress macrophage activation in vitro and alleviate chemically induced colitis in mice. Infect Immun (2009) 1.06
Increasing incidence of inflammatory bowel disease among young men in Korea between 2003 and 2008. Dig Dis Sci (2010) 1.05
Genes and environment: how will our concepts on the pathophysiology of IBD develop in the future? Dig Dis (2010) 1.03
The phosphorycholine moiety of the filarial nematode immunomodulator ES-62 is responsible for its anti-inflammatory action in arthritis. Ann Rheum Dis (2007) 1.02
Trichinella spiralis: infection reduces airway allergic inflammation in mice. Exp Parasitol (2010) 1.02
The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. Clin Exp Immunol (2009) 1.01
A calreticulin-like molecule from the human hookworm Necator americanus interacts with C1q and the cytoplasmic signalling domains of some integrins. Parasite Immunol (2001) 1.00
Calreticulin from the intestinal nematode Heligmosomoides polygyrus is a Th2-skewing protein and interacts with murine scavenger receptor-A. Mol Immunol (2008) 0.99
The landscape of human genes involved in the immune response to parasitic worms. BMC Evol Biol (2010) 0.99
Progression of inflammatory bowel disease in China. J Dig Dis (2010) 0.98
Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems. J Biomed Biotechnol (2010) 0.95
Schistosoma mansoni infection modulates the immune response against allergic and auto-immune diseases. Mem Inst Oswaldo Cruz (2004) 0.94
Mechanisms of modulation of experimental autoimmune encephalomyelitis by chronic Trichinella spiralis infection in Dark Agouti rats. Parasite Immunol (2010) 0.93
Current status of parasitic diseases. Public Health Rep (1955) 0.92
Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes. J Biomed Biotechnol (2010) 0.92
Spontaneous arthritis in MRL/lpr mice is aggravated by Staphylococcus aureus and ameliorated by Nippostrongylus brasiliensis infections. Autoimmunity (2009) 0.92
Infection with an intestinal helminth parasite reduces Freund's complete adjuvant-induced monoarthritis in mice. Arthritis Rheum (2011) 0.91
The inhibitory effect against collagen-induced arthritis by Schistosoma japonicum infection is infection stage-dependent. BMC Immunol (2010) 0.87
Helminths as governors of inflammatory bowel disease. Gut (2008) 0.86
Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Pract Gastroenterol Hepatol (2005) 0.84
Trichuris suis might be effective in treating allergic rhinitis. J Allergy Clin Immunol (2010) 0.83
The epidemiology of inflammatory bowel diseases in Finland. Scand J Gastroenterol (2010) 0.79
Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology (2005) 5.26
Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol (2003) 3.40
Exposure to schistosome eggs protects mice from TNBS-induced colitis. Am J Physiol Gastrointest Liver Physiol (2002) 2.28
Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology (2002) 2.27
Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice. Eur J Immunol (2004) 1.92
Mechanisms of disease: the hygiene hypothesis revisited. Nat Clin Pract Gastroenterol Hepatol (2006) 1.89
Alteration of the murine gut microbiota during infection with the parasitic helminth Heligmosomoides polygyrus. Inflamm Bowel Dis (2010) 1.85
Granulomas in schistosome and mycobacterial infections: a model of local immune responses. Trends Immunol (2003) 1.75
Intestinal helminths protect in a murine model of asthma. J Immunol (2006) 1.64
Helminths as governors of immune-mediated inflammation. Int J Parasitol (2006) 1.59
Colonization with Heligmosomoides polygyrus suppresses mucosal IL-17 production. J Immunol (2008) 1.35
Heligmosomoides polygyrus promotes regulatory T-cell cytokine production in the murine normal distal intestine. Infect Immun (2007) 1.35
Induction of CD8+ regulatory T cells in the intestine by Heligmosomoides polygyrus infection. Am J Physiol Gastrointest Liver Physiol (2006) 1.28
Differential regulation of CCL21 in lymphoid/nonlymphoid tissues for effectively attracting T cells to peripheral tissues. J Clin Invest (2003) 1.27
Treatment of Helicobacter gastritis with IL-4 requires somatostatin. Proc Natl Acad Sci U S A (2003) 1.19
Heligmosomoides polygyrus bakeri induces tolerogenic dendritic cells that block colitis and prevent antigen-specific gut T cell responses. J Immunol (2012) 1.17
Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis (2009) 1.17
Heligmosomoides polygyrus induces TLR4 on murine mucosal T cells that produce TGFbeta after lipopolysaccharide stimulation. J Immunol (2006) 1.15
Role of T cell TGF-beta signaling in intestinal cytokine responses and helminthic immune modulation. Eur J Immunol (2009) 1.12
Anti-interferon-inducible chemokine, CXCL10, reduces colitis by impairing T helper-1 induction and recruitment in mice. Inflamm Bowel Dis (2005) 1.11
Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma. J Exp Med (2006) 1.10
Signaling through Fc gamma RIII is required for optimal T helper type (Th)2 responses and Th2-mediated airway inflammation. J Exp Med (2007) 1.09
Heligmosomoides polygyrus infection can inhibit colitis through direct interaction with innate immunity. J Immunol (2010) 1.09
Coinfection with the intestinal nematode Heligmosomoides polygyrus markedly reduces hepatic egg-induced immunopathology and proinflammatory cytokines in mouse models of severe schistosomiasis. Infect Immun (2008) 1.02
Heligmosomoides polygyrus bakeri infection activates colonic Foxp3+ T cells enhancing their capacity to prevent colitis. J Immunol (2013) 0.97
Where are we on worms? Curr Opin Gastroenterol (2012) 0.96
Helminths and the modulation of mucosal inflammation. Curr Opin Gastroenterol (2005) 0.94
Established T(H1) granulomatous responses induced by active Mycobacterium avium infection switch to T(H2) following challenge with Schistosoma mansoni. Clin Immunol (2002) 0.93
Helminthic therapy: using worms to treat immune-mediated disease. Adv Exp Med Biol (2009) 0.91
CD4+ T cells from IL-10-deficient mice transfer susceptibility to NSAID-induced Rag colitis. Am J Physiol Gastrointest Liver Physiol (2004) 0.91
Cutting edge: hemokinin has substance P-like function and expression in inflammation. J Immunol (2004) 0.89
Substance P receptor mediated maintenance of chronic inflammation in EAE. J Neuroimmunol (2006) 0.88
IL-12 induction of mRNA encoding substance P in murine macrophages from the spleen and sites of inflammation. J Immunol (2005) 0.87
TGF-beta regulates T-cell neurokinin-1 receptor internalization and function. Proc Natl Acad Sci U S A (2010) 0.87
Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas. Infect Immun (2002) 0.86
Assessment of fractionated exhaled nitric oxide as a biomarker for the treatment of eosinophilic esophagitis. Allergy Asthma Proc (2013) 0.86
CD4+ TCR repertoire heterogeneity in Schistosoma mansoni-induced granulomas. J Immunol (2002) 0.86
ICOS costimulation expands Th2 immunity by augmenting migration of lymphocytes to draining lymph nodes. J Immunol (2008) 0.86
Is there a role for helminths in the therapy of inflammatory bowel disease? Nat Clin Pract Gastroenterol Hepatol (2005) 0.84
Interleukin-12 (IL-12) and IL-23 induction of substance p synthesis in murine T cells and macrophages is subject to IL-10 and transforming growth factor beta regulation. Infect Immun (2008) 0.83
Schistosoma mansoni proteins attenuate gastrointestinal motility disturbances during experimental colitis in mice. World J Gastroenterol (2010) 0.83
CD28 and ICOS play complementary non-overlapping roles in the development of Th2 immunity in vivo. Cell Immunol (2009) 0.83
Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma. Am J Respir Cell Mol Biol (2009) 0.83
Trichuris suis might be effective in treating allergic rhinitis. J Allergy Clin Immunol (2010) 0.83
T cell substance P receptor governs antigen-elicited IFN-gamma production. Am J Physiol Gastrointest Liver Physiol (2002) 0.82
Inducible costimulator expression regulates the magnitude of Th2-mediated airway inflammation by regulating the number of Th2 cells. PLoS One (2009) 0.82
Reduced CTL response and increased viral burden in substance P receptor-deficient mice infected with murine gamma-herpesvirus 68. J Immunol (2003) 0.81
Why Trichuris suis should prove safe for use in inflammatory bowel diseases. Inflamm Bowel Dis (2005) 0.81
Substance P expression correlates with severity of diarrhea in cryptosporidiosis. J Infect Dis (2003) 0.81
IL-4 inhibits vasoactive intestinal peptide production by macrophages. Am J Physiol Gastrointest Liver Physiol (2002) 0.78
Therapeutic colonization with Trichuris suis. Arch Pathol Lab Med (2006) 0.78